Stocktoria

Medpace Holdings, Inc. MEDP

Nasdaq · XNAS · stock · Services-Commercial Physical & Biological Research · website · IPO 2016-08-11
Chart by TradingView
6/9
Piotroski F — financial health
0.2
Altman Z″ — distress risk · distress
Dividend payout · no dividend

Valuation · market cap as of 2026-06-29

Market cap$15.1B
P / E33.4×
P / S5.9×
P / B32.8×
P / FCF22.1×

Financials & ratios (annual, from 10-K)

MetricFY2025FY2024FY2023FY2022FY2021
Financials
Revenue$2.5B$2.1B$1.9B$1.5B$1.1B
Operating income$534.9M$446.9M$336.8M$278.7M$198.6M
Net income$451.1M$404.4M$282.8M$245.4M$181.8M
Operating cash flow$713.2M$608.8M$433.4M$388.1M$263.3M
Free cash flow$681.9M$572.3M$396.7M$351.2M$235.1M
Total assets$2.0B$2.1B$1.7B$1.4B$1.7B
Total liabilities$1.5B$1.3B$1.1B$966.1M$707.0M
Shareholders' equity$459.1M$825.5M$559.0M$386.4M$952.9M
Ratios
Operating margin21.1%21.2%17.9%19.1%17.4%
Net margin17.8%19.2%15.0%16.8%15.9%
FCF margin26.9%27.1%21.0%24.1%20.6%
Return on assets22.8%19.2%17.1%18.1%11.0%
Return on equity98.3%49.0%50.6%63.5%19.1%
Current ratio0.740.930.640.421.24
Revenue growth20.0%11.8%29.2%27.8%23.4%

Notable holders (13F)

InvestorSharesValue
RENAISSANCE TECHNOLOGIES LLC504,668$242.3M
Bridgewater Associates, LP41,135$19.8M

Why these scores methodology →

Piotroski F-score: 6/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: 0.2 (distress)

  • Working capital / assets -0.179
  • Retained earnings / assets -0.233
  • EBIT / assets 0.271
  • Equity / liabilities 0.303

Sector peers

GOOG · MSFT · META · BABA · DIS · HCA · all Services →

Source: SEC EDGAR filings · CIK 0001668397 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.